pyrrolidine dithiocarbamate has been researched along with isobutyrylshikonin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, IW; Choi, YH; Dilshara, MG; Jayasooriya, RG; Kang, CH; Kim, GY; Lee, HJ; Lee, KT | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and isobutyrylshikonin
| Article | Year |
|---|---|
Isobutyrylshikonin inhibits lipopolysaccharide-induced nitric oxide and prostaglandin E2 production in BV2 microglial cells by suppressing the PI3K/Akt-mediated nuclear transcription factor-κB pathway.
Topics: Antioxidants; Cell Line; Central Nervous System Diseases; Cyclooxygenase 2; Dinoprostone; Down-Regulation; Inflammation; Inflammation Mediators; Lipopolysaccharides; Lithospermum; Macrophages; Microglia; Naphthoquinones; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphatidylinositol 3-Kinases; Phosphorylation; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-akt; Pyrrolidines; Signal Transduction; Thiocarbamates | 2014 |